“…The development of new antituberculotic agents is the principal goal of our group. Lately, we have studied a number of structurally different compounds, such as the derivatives of salicylamides [1], pyridine [2,3], alkoxyphenylcarbamic acids [4], tetrazoles [5,6], dihydroindolethiones [7], and other heterocycles [8,9]. Our research was strongly oriented to collaborate with German institutes like Technical University Dresden, Friedrich Schiller University Jena, Hans Knöll Institute Jena, and Maxmilian University in Munich.…”